Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGraphene Nanochem Regulatory News (GRPH)

  • There is currently no data for GRPH

Schedule 1 - Biofutures Int

1 Nov 2006 11:40

AIM01 November 2006 ANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT PRIOR TO ADMISSION IN ACCORDANCE WITH AIM RULE 2 ALL APPLICANTS MUST COMPLETE THE FOLLOWING: COMPANY NAME:Biofutures International plc COMPANY ADDRESS:8 - 12 PriestgatePeterborough COMPANY POSTCODE:PE1 1JA COUNTRY OF INCORPORATION:England COMPANY BUSINESS OR, IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITS INVESTMENT STRATEGY TO BE DISCLOSED INACCORDANCE WITH SCHEDULE 2, PARAGRAPH (J) OF THE AIM RULES:On 28 July 2006, Biofutures International plc announced that it had entered into a conditional agreement to acquireZurex Corporation Sdn. Bhd., a Malaysian company formed in November 2005 which holds a licence to produce biodieselderived from palm oil in Malaysia. Zurex has entered into a contract with POIC Sabah Sdn. Bhd., an entity set up by theSabah regional government of Malaysia to develop palm oil processing, to acquire a site on which it intends toconstruct a 200,000 tonnes per annum biodiesel plant. This transaction constitutes a reverse takeover under the AIM Rules. Biofutures International plc is applying for theadmission of its enlarged share capital to trading on AIM. DETAILS OF SECURITIES TO BE ADMITTED (i.e. where known, number of shares, nominal value and issue price to which itseeks admission and the number and type to be held as treasury shares):147,730,000 Ordinary Shares of 1p eachCAPITAL TO BE RAISED ON ADMISSION:£11,050,000 gross FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED DIRECTORS:DirectorsNicholas Wilding Gee Executive ChairmanJulie Patricia Pomeroy Finance DirectorPhillip John Carter Non-executive DirectorChristopher Ronald Price Non-executive Director Proposed DirectorsWong Kai Fatt Non-executive DirectorLim Kwee Gee Non-executive Director PERSON(S) INTERESTED IN 3% OR MORE OF THE ISSUER'S CAPITAL, EXPRESSED AS A PERCENTAGE OF THE ISSUED SHARE CAPITALBEFORE AND AFTER ADMISSION: Before Admission After AdmissionPhillip John Carter 45.2% 11.28%Thornhaugh HallRussel HillThornahughPeterborough PE8 6NJ M.D. Barnard & Co Limited 10.85% 2.71%17-21 New Centruy RoadLaindonBasildon SS15 6AG Artemis Investment Management Limited 6.78% 1.69%Cassini House57 St James' StreetLondon SW1A 1LD Gartmore Investment Management Limited 6.78% 7.11%8 Fenchurch PlaceLondon EC3M 4PB Modal Capital Partners Limited 5.43% 5.71%1 Cabot SquareLondon E14 4QJ UBS AG 5.43% 1.35%100 Liverpool StreetLondon EC2M 2RH Goldman Sachs Inc 5.29% 1.32%Peterborough Court133 Fleet StreetLondon EC4A 2BB MooreMacro Fund LP 4.88% 1.22%c/o Citco Fund Services (Bahamas) LimitedOne Montague PlaceEast Bay StreetPO Box N-4906 Nassau, BahamasSanlam Global Best Ideas Fund 3.26% 0.81%c/o 126 Jermyn StreetLondon SW1Y 4UJ Lim Kwee Gee Nil 23.20%1 Jalan Stulang BaruTaman Suria81100 Johor BahruJohorMalaysia Wong Kai Fatt Nil 9.03%47 Jalan Kenanga SD 9/8Bandar Sri Damansara52200 Kuala LumpurMalaysia NAMES AND ADDRESSES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE 2, PARAGRAPH (H) OF THE AIM RULES:N/A ANTICIPATED ACCOUNTING REFERENCE DATE:31 December EXPECTED ADMISSION DATE:24 November 2006 NAME AND ADDRESS OF NOMINATED ADVISER:Ruegg & Co Limited39 Cheval PlaceLondon SW7 1EW NAME AND ADDRESS OF BROKER:Hichens, Harrison & Co plcBell Court House11 Blomfield StreetLondon EC2M 1LB DETAILS OF WHERE (POSTAL OR INTERNET ADDRESS) THE ADMISSION DOCUMENT WILL BE AVAILABLE FROM, WITH A STATEMENT THAT THISWILL CONTAIN FULL DETAILS ABOUT THE APPLICANT AND THE ADMISSION OF ITS SECURITIES:The admission document will be available from the offices of DLA Piper UK LLP at 3 Noble Street, London EC2V 7EE andwill contain full details about the applicant and its securities DATE OF NOTIFICATION:1 November 2006 NEW/ UPDATE (see note):New This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
16th Mar 20187:00 amRNSAcquisition Update and AIM Cancellation
16th Feb 20187:00 amRNSConfirmation of Resignation of Nomad and Broker
31st Jan 20181:47 pmRNSNotice of Resignation of Nomad and Broker
17th Jan 20189:24 amRNSResignation of Director
8th Jan 20182:50 pmRNSProposed Acquisition Update
30th Nov 20177:30 amRNSSuspension - Graphene Nanochem Plc
30th Nov 20177:00 amRNSProposed Acquisition and Suspension of Trading
12th Oct 20174:40 pmRNSSecond Price Monitoring Extn
12th Oct 20174:35 pmRNSPrice Monitoring Extension
11th Oct 20174:40 pmRNSSecond Price Monitoring Extn
11th Oct 20174:35 pmRNSPrice Monitoring Extension
29th Sep 201711:30 amRNSInterim Results
13th Sep 20179:31 amRNSHolding(s) in Company
13th Sep 20179:27 amRNSHolding(s) in Company
11th Sep 201712:07 pmRNSSecond Price Monitoring Extn
11th Sep 201712:02 pmRNSPrice Monitoring Extension
11th Sep 201711:45 amRNSConversion of Loan Notes and Issue of Equity
4th Sep 201710:15 amRNSConversion of loan note and issue of equity
2nd Aug 20171:20 pmRNSConversion of loan note and issue of equity
26th Jul 201711:30 amRNSResult of Annual General Meeting
4th Jul 20179:59 amRNSConversion of loan note and issue of equity
30th Jun 20177:03 amRNSPreliminary Results
27th Jun 20174:35 pmRNSPrice Monitoring Extension
23rd Jun 20174:35 pmRNSPrice Monitoring Extension
13th Jun 20177:00 amRNSPolymer Division Paid Pilot
22nd May 201712:54 pmRNSPlatDrill Deployment In Myanmar
15th May 201712:35 pmRNSIssuance of Tranche 2 Loan Notes
12th Apr 20172:47 pmRNSConversion of loan note and issue of equity
3rd Apr 201711:47 amRNSConversion of Loan Note and Issue of Equity
31st Mar 20179:05 amRNSUpdate on Debt Rationalisation
8th Mar 201712:00 pmRNSConversion of loan note and issue of equity
3rd Mar 20177:00 amRNSCommercial deployment in Turkmenistan
20th Feb 20174:40 pmRNSSecond Price Monitoring Extn
20th Feb 20174:35 pmRNSPrice Monitoring Extension
3rd Feb 20177:00 amRNSConversion of loan note and issue of equity
29th Dec 20164:19 pmRNSFurther information on 2015 report and accounts
28th Dec 20167:00 amRNSContract Win
23rd Dec 201612:35 pmRNSPrice Monitoring Extension
23rd Dec 20168:45 amRNSRestoration - Graphene NanoChem PLC
23rd Dec 20168:15 amRNSIssuance of Loan Notes and Resumption of Trading
6th Dec 20162:44 pmRNSResult of AGM
14th Nov 20165:04 pmRNSInterim Results
14th Nov 20165:01 pmRNSProposed Share Capital Reorganisation
14th Nov 20165:00 pmRNSPreliminary Results
31st Oct 20164:35 pmRNSUpdate on pending 2015 Annual Results
30th Sep 20163:20 pmRNSUpdate on 2015 Annual Results & 2016 Interims
1st Sep 20161:21 pmRNSUpdate on pending 2015 Annual Results
29th Jul 20167:00 amRNSUpdate on pending 2015 Annual Results
29th Jun 20167:30 amRNSStatement re. Suspension
29th Jun 20167:30 amRNSSuspension - Graphene Nanochem Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.